Solutions

View 10 related solutions for Late Phase Partnerships

Solutions

Late Phase Partnerships

As today’s biopharmaceutical companies look for faster, more efficient routes to market, one thing has become clear – having the right partner can make all the difference.

PAREXEL PACE™ (Peri-Approval Clinical Excellence), PAREXEL®’s group of experts dedicated to late phase research, offer a proven partnership model designed specifically for Late Phase. We are committed to offering innovative solutions that address the unique needs facing pharmaceutical companies as they transition products from clinical development to commercialization. From a global infrastructure to some of the most brilliant minds in the industry, the PAREXEL PACE group stands beside you as your partner to help you achieve late phase success.

Contact us today to learn how a partnership with PAREXEL can enhance your late phase programs. 

Key Materials

Readying Your Science for the Real World

Learn why drug development today is more than a process. It's a journey. Click here.

Explore Late Phase Partnerships
All Solutions
All Solutions
Clinical Research
Informatics
Consulting

View More...

Peri/Post-Approval Services

More Tools to Simplify Your Journey Before and After Approval When it’s time to shift your development journey toward commercialization to gain first market access, PAREXEL® is the partner to help you do it…seamlessly, securely, and cost-effectively.

read more

Study Management and Monitoring

Clinical trials constitute the single most expensive component of the entire drug development process. In particular, clinical trial operations represent one of the most resource-intensive areas within a biopharmaceutical company and often involve tedious, manual processes for collecting, aggregating and rationalizing information from a wide variety of data sources.

read more

Regulatory Information Management

Regulatory Information Management (RIM) is defined as the effective and efficient collection, storage, retrieval and communication of regulatory information. RIM processes include defining product authorization targets, managing regulatory submission plans, creating and gathering submission information, producing and submitting the submission output and managing the product registration.

read more

Perceptive MyTrials®

Single-Point Access to Both Data and Applications to Simplify Your Journey When your journey heads into clinical trials, accessing data, information, and all the applications you need from a single place saves untold time and agitation. That’s what Perceptive MyTrials from PAREXEL® does.

read more

Clinical Data Management

The DataLabs® EDC solution is uniquely focused on simplifying workflows and delivering superior user experiences. Its advanced EDC features help streamline the entire process starting from study design all the way to collection, management and reporting of clinical trial data.

read more

Randomization and Trial Supply Management

PAREXEL Informatics™ provides automated randomization and supplies management through its ClinPhone® RTSM (Randomization and Trial Supply Management) solution. Our services are offered by the industry's most experience and trusted provider of IVR (Interactive Voice Response) and IWR (Interactive Web Response) technologies.

read more

Clinical Outcome Assessments / ePRO

Clinical Outcome Assessments (COAs) measure a patient’s symptoms, overall mental state, or the effects of a disease or condition on how the patient functions. COAs can be used to determine whether or not a drug has been demonstrated to provide treatment benefit. COA types include ePRO (electronic Patient Reported Outcomes).

read more

Integrated Product Development

Journeys, of course, have varied destinations. But whether you’re taking a new molecule to market, exploring how to differentiate a current product, or evaluating new geographic options, PAREXEL®’s Integrated Product Development team can shorten your product’s time to market and provide the strategic bandwidth and marketplace resources to help that product achieve more commercially.

read more

HERON™ Commercialization

In this post-blockbuster era, traditional opportunities for sustained growth throughout your products’ long-term journey are limited. Biologics, biomarkers, genomics, personalized medicine, and proteomics offer promising alternatives, but commercial dynamics of the biopharmaceutical industry are uncertain.

read more

Medical Communications

Successful commercialization is no longer just about gaining regulatory approval. It is about meeting the needs of a growing number of stakeholders, including physicians, patients, governments and payers. Success requires integrated pharmaceutical teamwork, including the right Medical Communications expertise where needed, to address the traditional silos of R&D, marketing and regulatory and focus on the same goals.

read more